Search results
Results from the WOW.Com Content Network
CAMBRIDGE, Mass., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced the sale of certain future license fees and other payments owed to Editas Medicine under its Cas9 license agreement with Vertex Pharmaceuticals to a wholly-owned subsidiary of DRI Healthcare Trust (DRI) for an upfront cash payment of $57 million.
Editas Medicine was originally founded with the name "Gengine, Inc." in September 2013 by Feng Zhang of the Broad Institute, Jennifer Doudna of the University of California, Berkeley, [7] and George Church, David Liu, and J. Keith Joung of Harvard University, with funding from Third Rock Ventures, Polaris Partners and Flagship Ventures; the name was changed to the current "Editas Medicine" two ...
Editas' (EDIT) portfolio currently lacks an approved product. The focus of third-quarter earnings call was on its pipeline development. Editas (EDIT) Beats on Q3 Earnings, Amends Celgene Deal
Jasmine Directory - Lists websites by topic and by region, specializing in business websites. Sources – general subject web portal for journalists, freelance writers, editors, authors and researchers; in addition to a search engine it includes a subject-based directory. World Wide Web Virtual Library (VLIB) – oldest directory of the Web.
List of satirical fake news websites; List of satirical news websites; List of search engines; List of soap opera media outlets; List of social bookmarking websites; List of social networking services; List of defunct social networking services; List of street view services
For premium support please call: 800-290-4726 more ways to reach us
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
This is a list of most-visited websites worldwide as of November 2024, along with their change in ranking compared to the previous month. List This is a dynamic list and may never be able to satisfy particular standards for completeness.